Latest News

The United States market has shown robust performance, rising 1.7% over the past week and climbing 34% in the last year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying lesser-known stocks with strong growth potential can offer unique opportunities for investors seeking to capitalize on emerging trends.

New Found Gold Corp. recently secured a CA$105 million senior secured credit facility from EdgePoint Capital Advisors and filed a CA$100.048 million follow-on equity offering to help fund Phase I development of its Queensway Gold Project, alongside reporting final 2025 drilling results that expanded the Dropkick Zone. Together, the financing package and confirmation that Dropkick remains open along strike and at depth highlight both funding access and geological upside for Queensway’s...

Leapmotor (SEHK:9863) has introduced the D19, described as the world's first premium SUV using a centralized QNX based software platform. The system integrates the digital cockpit, advanced driver assistance, and connectivity functions into a single safety certified domain. This launch marks the first mass produced vehicle to consolidate these core software defined features on advanced QNX platforms. For investors watching the electric vehicle space, this move puts software architecture at...

Randstad (ENXTAM:RAND) opened 2026 with first quarter revenue of €5.5b and basic EPS of €0.35. This helps illustrate how its earnings story is developing after a year in which trailing twelve month EPS reached €1.57 on revenue of €22.9b and net income of €276m. Over the past five reported quarters, revenue has moved between €5.5b and €6.1b, while quarterly basic EPS has ranged from a loss of €0.86 to a profit of €0.50. Trailing net profit margin most recently sat at 1.2% compared with 0.4% a...

This article examines whether Science Applications International might represent value at its current share price by walking through what the numbers are actually indicating about the stock. With a share price of US$95.71 and a 16.5% gain over five years, recent returns have been softer, with the stock down 0.5% over the past week, 1.2% over the past month, 5.4% year to date and 19.0% over the last year. Recent headlines around Science Applications International have focused on its role as a...

If you are wondering whether Lam Research shares still offer value after a strong run, or if you are turning up late to the party, this breakdown can help you frame the risk and reward trade off more clearly. The stock closed at US$265.55 and has posted returns of 0.1% over 7 days, 13.8% over 30 days, 43.5% year to date, 300.9% over 1 year, 449.5% over 3 years and 339.0% over 5 years. Recent headlines around Lam Research have focused on its role in semiconductor equipment, its exposure to...

Wondering whether Valley National Bancorp at around US$13.25 is offering fair value or an appealing entry point? This article walks through what the current price could imply for you as a shareholder. The stock has moved 0.8% over the last 7 days, 10.4% over the past month, 13.3% year to date, 60.0% over 1 year and 78.5% over 3 years, compared with a 17.8% return over 5 years. Recent coverage has focused on how regional banks are being reassessed by investors, and how balance sheet strength,...

Medline stock snapshot after recent moves Medline (MDLN) has attracted fresh attention after recent trading, with the share price at $47.16 and single-day, week, and month returns of around 1%, 2%, and 11% respectively. See our latest analysis for Medline. Over the past month Medline has logged an 11.0% share price return and a 16.1% year to date share price return, suggesting near term momentum is firming even though very short term moves have been softer. If you are comparing Medline with...

Moody's (MCO) opened 2026 with Q1 revenue of US$2.1b and basic EPS of US$3.74, setting the tone for how its profitability story is developing against a US$466.72 share price. Over recent quarters, revenue has moved from US$1.67b in Q4 2024 to between US$1.89b and US$2.08b across the last five reported periods, while quarterly basic EPS ranged from US$2.18 to US$3.74, underscoring how earnings power has tracked alongside higher net income figures. With a trailing net margin cited at 31.7%, the...

Highwoods Properties (NYSE:HIW) has authorized a $250 million share repurchase program. The company plans to fund the buybacks through sales of non core assets in its portfolio. The move reflects a shift in how Highwoods is choosing to allocate capital between assets and its own shares. Highwoods Properties enters this announcement with its shares recently closing at $23.74. The stock is up 2.4% over the past week and 11.7% over the past month, while the year to date return stands at a...

In April 2026, Andretti Performance announced a partnership making Velo3D the official sponsor and additive manufacturing technology provider for two 2026 IMSA Michelin Pilot Challenge events, featuring Velo3D branding on the No. 43 Porsche at Laguna Seca and Indianapolis and race-ready components produced with its metal 3D printing systems. A custom aluminum CP1 radio controls mounting bracket, produced using Constellium’s Aheadd CP1 alloy and generative design tools, puts Velo3D’s...

Recent share performance and business overview Dream Finders Homes (DFH) has drawn attention after recent share price moves, with a return of about 10% over the past month and a decline of roughly 19% over the past 3 months. The US homebuilder, headquartered in Jacksonville, Florida, reports revenue of about US$4.3b and net income of roughly US$203.7m. This reflects its mix of single family homebuilding and related financial services across several regional segments. See our latest analysis...

EQT (EQT) kicked off Q1 2026 with revenue of US$3.6 billion and basic EPS of US$2.38, alongside trailing twelve month revenue of US$9.4 billion and EPS of US$5.31. This sets a clear earnings bar for investors tracking the story. Over recent quarters the company has seen revenue move from US$2.4 billion in Q1 2025 and US$1.8 billion in Q4 2024 to US$3.6 billion in the latest quarter. Basic EPS has increased from US$0.40 and US$0.70 in those same periods to US$2.38, putting the focus firmly on...

If you are wondering whether California Resources at around US$64.65 is still offering value or starting to look fully priced, this breakdown will help you make sense of what the current market price might be implying. The stock has been relatively flat over the last 7 days with a 0.4% decline, but over longer periods it has delivered returns of 1.3% over 30 days, 39.4% year to date, 91.4% over 1 year, 81.2% over 3 years and 207.3% over 5 years. Recent coverage of California Resources has...

Ardelyx (NasdaqGM:ARDX) appointed Felecia W. Ettenberg as Chief Legal Officer, succeeding Elizabeth Grammer. The transition follows Grammer’s 16 year tenure in the role. Ettenberg brings extensive legal and regulatory experience from a leading pharmaceutical company. Ardelyx focuses on therapies in the biopharmaceutical space, where regulatory scrutiny, patent protection, and compliance requirements shape how companies operate. A new Chief Legal Officer sits at the center of these issues,...

If you are wondering whether Hitachi's share price still offers value after a strong run, it helps to line up the recent returns against what the current valuation is actually saying. The stock last closed at ¥5,230, with returns of 0.2% over 7 days, 8.7% over 30 days, 3.2% year to date, 48.6% over 1 year and a very large gain over 5 years. Recent coverage has focused on Hitachi's role in capital goods and infrastructure, which keeps attention on how its core businesses are positioned, and...

If you are wondering whether Merchants Bancorp at around US$49.43 is still attractively priced after its recent run, this article walks through what the current valuation might be telling you. Over the short term, the stock has posted returns of 5.5% over 7 days and 18.6% over 30 days, with longer term returns of 49.0% year to date and 53.5% over 1 year providing useful context for where sentiment currently sits. Recent company news, regulatory filings or sector updates help explain why...

If you are considering whether Century Communities at around US$63.82 represents value or risk, this breakdown can help you understand what you are actually paying for. The share price has recently been active, with returns of 8.5% over 7 days, 11.0% over 30 days, and 8.3% year to date. This may be of interest if you are tracking momentum and changes in sentiment. Recent coverage has focused on Century Communities as part of a broader look at US homebuilders, with attention on how individual...

Why ZenaTech’s latest expansion is on investors’ radar ZenaTech (ZENA) is drawing attention after opening new offices in Seoul and London. These moves are aimed at supporting its ZenaDrone, Drone as a Service, and enterprise SaaS operations across APAC and EMEA. See our latest analysis for ZenaTech. At a share price of $2.24, ZenaTech has seen a 9.27% 1 day share price return and 5.66% 7 day share price return, but a 55.47% 90 day share price decline. Its 1 year total shareholder return of...

Digital Core REIT (SGX:DCRU) reported Q1 2026 revenue of US$44.1 million and basic EPS of US$0.004, setting a cautious tone for investors tracking its latest update. Over recent periods, revenue has moved between US$39.8 million in Q4 2024 and US$63.1 million in Q3 2025, while basic EPS has ranged from US$0.139 in Q4 2024 to US$0.022 in Q4 2025, providing a mixed picture of earnings power across the last few quarters. With trailing 12 month profit margins at 26.2% and a large one off gain...

GE HealthCare Technologies (NasdaqGS:GEHC) has dosed the first patient in its Phase 2/3 LUMINA trial for mangaciclanol, a manganese based MRI contrast agent. The agent holds FDA Fast Track designation and is being studied as a potential alternative to gadolinium based contrast agents. The company highlights potential benefits related to patient safety, supply reliability, and reduced reliance on rare earth elements. GE HealthCare enters this trial with its shares at $71.38 and a mixed...

Triple I partnership brings Faraday Future’s AI robotics into classrooms Faraday Future Intelligent Electric (FFAI) has drawn fresh attention after partnering with education institution Triple I to launch an Embodied AI robotics summer camp and broader EAI education programs in Irvine, California. This education focused move links the company’s EAI robots directly with K 12 students, parents, and teachers, giving investors a clearer view of how Faraday Future aims to apply its robotics...

Biogen (NasdaqGS:BIIB) has acquired exclusive rights to felzartamab in the Greater China Region from TJ Biopharma. The deal consolidates global rights to felzartamab, an antibody in Phase 3 trials for multiple immune mediated diseases. Biogen will lead development and commercialization of felzartamab in Greater China, a key market for conditions such as IgAN and PMN. For investors tracking Biogen, this move adds a late stage immunology asset to a pipeline already focused on serious...

If you are wondering whether Xcel Energy’s share price still reflects fair value or if the market is overlooking something, this article breaks down what the current price might be telling you. The stock last closed at US$78.11, with returns of 1.5% over 30 days and 12.6% over the past year. This may signal that market expectations and perceived risk have shifted over time. Recent attention on utilities, energy infrastructure and the broader power grid has kept Xcel Energy on many investors’...